Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The validation encompasses Ecolab’s near- and long-term greenhouse gas (GHG) emissions targets.
November 12, 2024
By: Charlie Sternberg
Ecolab Inc.’s climate targets have been approved by the Science-Based Targets initiative (SBTi), the gold standard for climate target verification. The validation encompasses Ecolab’s near- and long-term greenhouse gas (GHG) emissions targets and bolsters the company’s track record in its journey to achieve net-zero emissions across its value chain. “Ecolab is committed to achieving our ambitious climate targets and making an even greater positive impact with our customers,” said Christophe Beck, Chairman and CEO, Ecolab. “By decarbonizing our business and empowering our customers to do the same, we are driving positive business performance while helping tackle the urgent challenge of climate change.” As part of its decarbonization strategy, Ecolab has sourced more than 80% of its electricity globally from renewable sources and is accelerating the electrification of its vehicle fleet. Through 2023, Ecolab achieved a 25% reduction in absolute Scope 1 and 2 carbon emissions, surpassing the 10% average reduction reported by WEF Alliance of CEO Climate Leaders members. Additionally, Ecolab helped avoid 3.8 million metric tons of greenhouse gas emissions through collaboration with its customers in 2023. “Science-based targets are a critical component of Ecolab’s rigorous climate resilience strategy,” said Emilio Tenuta, Senior Vice President and Chief Sustainability Officer, Ecolab. “As we proceed on our pathway toward net-zero emissions by 2050—and halfway there by 2030—Ecolab is making marked improvements in our operational efficiency while expanding our positive impact.” Ecolab’s SBTi-approved targets include:
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !